Brainscape's Knowledge GenomeTM

Browse over 1 million classes created by top students, professors, publishers, and experts.


See full index

SFM2 > Pharmacology > Flashcards

Pharmacology Flashcards

1
Q

neostigmine

A

cholinergic agonist
quaternary acetylcholinesterase (does not cross BBB)
reverses anesthetic paralysis
SLUDGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

pyridostigmine

A

cholinergic agonist
long(est) acting acetylcholinesterase, quaternary (does not cross BBB)
preferred drug in myasthenia gravis
SLUDGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

physostigmine

A

cholinergic agonist
tertiary acetylcholinesterase (does cross BBB = CNS effects)
antidote for atropine
SLUDGE, convulsions, coma

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

pralidoxime

A

cholinergic ANTagonist
regenerates acetylcholinesterase
treats OD on cholinergic agonists
anti-SLUDGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

benzocaine

A

local anesthetic, ester
topical-only anesthetic
if internal use, serious methylglobinemia –> cyanosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

tetracaine

A

local anesthetic, ester

long-duration LA used for spinal anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

mechanism of action of all local anesthetics

A

blocks Na+ channels on nociceptive receptors, especially small and unmyelinated neurons

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

adverse events of all local anesthetics if they are administered IV

A

v tach, v fib, other potential arrythmias, heart block, bradypenia, hypotension, convulsions, coma, possible death

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

lidocaine

A

local anesthetic, amide

most commonly used LA, intermediate duration, can be topical, injected subQ, spinal anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

bupivicaine

A

local anesthetic, amide
long duration, used for epidurals
heart problems are especially severe if IV

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

atropine

A

anti-cholinergic muscarinic antagonist
blocks downstream muscarinic signalling (G-protein pathway)
has CNS effects, antidote to acetylcholinesterase inhibitors (anti-SLUDGE), treats bradycardia, bedwetting, pupil dilation
can cause tachycardia, hyperthermia, delirium, dizziness, anti-SLUDGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

scopolamine

A

anti-cholinergic muscarinic antagonist
blocks downstream muscarinic signalling (G-protein pathway)
long-acting and has CNS effects - prevents vomiting from motion sickness, surgery, etc.
sedation, confusion, anti-SLUDGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

glycopyrrolate

A

anti-cholinergic muscarinic antagonist
blocks downstream muscarinic signalling (G protein pathway)
similar to atropine, but in PNS only: anti-acetylcholinesterase, bradycardia, etc.
like atropine, tachycardia, anti-SLUDGE (no CNS side effects like delirium, dizziness, hyperthermia)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

botox

A

anticholinergic
cleaves SNAREs that are needed for neurotransmitter vesicle fusion to pre-synaptic membrane, so ACh is not released
spasm, strabismus, dystonia, hyperhydrosis (execs sweating), tension/migraine headache, cosmetics
3-6 months duration

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

pilocarpine

A

cholinomimetic muscarinic agonist
direct muscarinic agonist = directly binds to muscarinic receptor and induces G protein signalling
ciliary contraction in glaucoma, tear and salivary gland production in Sjorjen’s syndrome
SLUDGE

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

tubocurarine

A

non-depolarizing NMJ blocker (curare)
nicotinic receptor competitive antagonist (binds active site) without depolarizing post-synaptic membrane
no longer used d/t many side effects, but is the parent compound for other curares

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

atracurarium

A

non-depolarizing NMJ blocker (curare)
as with other curares, nicotinic receptor competitive antagonist (blocks active site) without post-synaptic membrane depolarization
no CNS effects, intermediate-acting time
anesthetic paralysis and intubation
of currently used curares, most likely to cause side fx: widespread histamine, PNS neurotoxin (e.g. seizure)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

rocurarium

A

non-depolarizing NMJ blocker (curare)
as with other curares, non-depolarizing nicotinic receptor competitive antagonist
no CNS effects, short-acting
anesthetic paralysis
similar side fx to other curares but less extreme d/t more quickly metabolized

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

succinylcholine

A

depolarizing NMJ blocker
step 1: ACh mimetic, causes widespread vasiculations
step 2: desensitization/receptor fatigue
step 3: broken down by plasma pseudocholinesterase
rapid onset (<1 min) and short duration (<10 min)
in genetically susceptible individuals (pseudocholinesterase mutations), effects can last for several hours

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

sugammedex

A

NMJ blockade reversal
releases/sequesters non-depolatorizing NMJ blocker from active site of nicotinic receptor, restoring normal signalling. sugammedex-curare complex then excreted renally.
reverses effects of non-depolarizing NMJ blockers
reasonably safe, fast-acting

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

aspirin

A

non-selective COX inhibitor, primarily COX1
IRREVERSABLE acetylation by acting as a steric block on COX.
anti platelet in addition to normal NSAID antiinflammatory antipyretic analgesic fx
Aspirin itself is rapidly excreted (within an hour) but effects last as long as it takes to make new COX/platelets
possible Reye’s syndrome in kids but this is being questioned now
Most GI effects of the NSAIDs because it is most partial to COX1; also, renal compromise and salycism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

ibuprofen

A

non-selective COX inhibitor, about 50:50 COX1:COX2
anti-inflammatory, anti pyretic, analgesic
t1/2 = 2-2.5 hour, reversible
competitive inhibition of arachidonic acid binding, which prevents arachadonic acid –> prostaglandin rxn. prostaglandins cause vasodilation, capillary permeability, platelet aggregation
AEs: GI bleeding, kidney compromise

23
Q

naproxen

A

non-selective COX inhibitor, about 60:40 COX1:COX2

similar to ibuprofen, but slightly less selective and much longer t1/2 (12-16 h)

24
Q

indomethacin

A

non-selective COX inhibitor, slightly less COX2 than naproxen
similar to ibuprofen, but less selective and intermediate t1/2 (4-6 h)
better for gout than other NSAIDs

25
Q

celecoxib

A

COX2 inhibitor
too bulky to fit in COX1 binding site = fewer side fx, stronger
moderate-to-severe inflammatory pain e.g.. OA, RA, ankylosing spondylitis
fewer GI fx, no platelet fx

26
Q

acetaminophen

A

non-opioid analgesic; it’s own class
for mild pain and fever. no anti-inflammatory fx.
Inhibits COX by different mechanism than NSAIDs but it’s not completely known how
liver toxicity at >3000 mg/day, no platelet fx, not contraindicated in asthma

27
Q

diazepam

A

benzodiazepine (Valium), antispasmodic at CNS level
GABA-A receptor allosteric agonist
potentiates GABA effects: facilitates GABA binding to receptor (Cl- channel) –> hyerpolarization and post-synaptic neuron inhibition
memory problems, agitation, hallucinations, mood changes, clumsiness, slurred speech …

28
Q

baclofen

A

antispasmodic/muscle relaxant at CNS level
GABA-B receptor agonist
directly activates GABA receptors leading to more K+ efflux, hyper polarization, and post-synaptic neuron inhibition
dizziness, weakness, confusion, headache, drowsiness…

29
Q

gabapentin

A

AED/anti-spasmodic/neuropathic pain/adjuvant at CNS level
similar effects to GABA but doesn’t actually have any effect on GABA receptors
prevents neurotransmitter release by blocking pre-synaptic Ca++ channels
no significant drug interactions, no liver metabolism (excreted directly into urine)
drowsiness, dizziness, headache, uncontrollable shaking (seizure-like event), anxiety, loss of balance…

30
Q

tizanidine

A

antispasmodic/muscle relaxant
presynaptic alpha-2 adrenergic receptor agonist
treats spasms, cramping, muscle tightness associated with MS, back pain, or spinal injuries
dizziness, drowsiness, weakness, paresthesias…

31
Q

dantrolene

A

anti-spasmodic/muscle relaxant, not strictly speaking an NMJ drug
binds ryanidine receptor to prevent release of calcium from the sarcoplasmic reticulum

32
Q

list opioid agonists from most potent to least

A 
fentanyl (>80x morphine)
hydromorphone
heroin
morphine ~ oxycodone (fewest off-target side fx)  ~ methadone
tramadol (1/10 morphine)
tapentadol
codeine
33
Q

opioid agonists: PD, sfx

A

act on endogenous pre- and post-synaptic opioid receptors (mu, kappa, delta = MOP, KOP, DOP) to INHIBIT neuron transmission

3 possible mechanisms:

  • adenylate cyclase inhibition (cAMP)
  • reduced Ca++ influx at pre-synaptic (inhibits nt release)
  • increase K+ efflux post-synaptic (hyperpolarized)

associated with range of opioid effects analgesia, euphoria (sometimes dysphoria), miosis (eye), respiratory depression, constipation, nausea, vomiting, cough suppression, hypogonadism long term d/t endocrine (GnRH, LH, FSH) inhibition, urinary retention, gallbladder spasm, histamine release, truncal rigidity, addiction, tolerance

34
Q

buprenorphine

A

opioid partial mu receptor agonist (kappa receptor antagonist)
ceiling effect to many pharmacologic effects including analgesia and euphoria
high binding affinity to receptors, naloxone minimally effective
less misuse potential, used in opioid use disorder

35
Q

naloxone

A

competitive opioid receptor antagonist
t1/2 = 1-2 hours (multiple injections or continuous infusions needed)
poor oral bioavailability

36
Q

naltrexone

A

competitive opioid receptor antagonist
longer acting than naloxone
t1/2 4 hours, also produces active metabolite with t1/2 = 12-16 hours
good p.o. bioavailability
can be used for OD or withdrawal maintenance in opioid use disorder

37
Q

loperamide

A

opioid agonist
used to treat diarrhea
does not cross BBB, does cross gut but rapidly metabolized so very little in systemic circulation

38
Q

diphenoxylate

A

opioid agonist

used to treat diarrhea - does not cross gut or BBB

39
Q

dextromethorphan

A

opioid agonist and glutamate NMDA receptor antagonist
used to treat cough several potential mechanisms - recent double blind studies show little to no effect
a codeine analog
no analgesic, gi, sedative fx
OTC

40
Q

codeine

A

opioid agonist
used to treat cough via CNS effects - weak opioid with less addictive potential
recent double-blind studies show little to no efficacy, older double-blind studies show good efficacy, reasons for discrepancy not know

41
Q

AEDs for pain

A

topiramate, lamotrigine, carbamate
all block Na+ channels
topiramate also block Ca++ channels and inhibits glutamate release
lamotrigine also blocks Ca++ channels and potentiates GABA effects

(gabapentin also technically AED, Ca++ channel blocker)

42
Q

amitriptyline

A

tricyclic antidepressant, adjuvant analgesic for neuropathic pain
inhibits norepinephrine and serotonin reuptake (by NET and SERT)
Na+ channel blocking
inhibit ascending nociceptive activity

“tricyclic” = 3 cyclic rings

43
Q

duloxetine

A

SNRI, adjuvant analgesic for neuropathic pain (Cymbalta)
inhibits norepinephrine and serotonin reuptake (by NET and SERT)
Na+ channel blocking
inhibit ascending nociceptive activity

44
Q

ketamine

A

non-competitive NMDA receptor antagonist
may potentiate GABA activation
induces dopamine
weak mu opioid receptor agonist

persistent NMDA activation by glutamate –> hyperexitability is one mechanism of central pain @spinal cord

45
Q

capsaicin

A

destroys nerve endings, differential effect on small and unmyelinated neurons such as nociceptive

46
Q

hydrocortisone/cortisol

A

glucocorticoid

47
Q

prednisone/prednisolone

A 
glucocorticoid 4x cortisol
short half life, low cost
fewer mineralocorticoid (Na+/K+) effects

prednisone = prodrug to prednisolone
prednisolone commonly prescribed in liver failure when prednisone can’t be broken down

48
Q

methylprednisolone

A

glucocorticoid 5x cortisol

commonly used for allergy and most autoimmune diseases

49
Q

dexamethasone

A

glucocorticoid 25x cortisol
t1/2 = 1-2 days
drug of choice for most long-acting purposes, e.g. allergy and autoimmune diseases

50
Q

morphine PK

A

no ceiling for analgesia (more drug = less pain), dose limited by side fx
peak 30 min to 1 h after administration, t1/2 = 2-3.5h
active metabolite as well as direct morphine effects
limited oral bioavailability

51
Q

methadone PK

A

t1/2 = 1-1.5 days, analgesic effect only 4-6 hours
milder withdrawal symptoms hence utility in opioid use disorder
excellent oral bioavailability
7-8x morphine
also an NMDA antagonist so useful in neuropathic pain

52
Q

NMDA is a receptor for…

A

glutamate. excitatory. ionotropic.

53
Q

mechanism of action glucocorticoids

A

phospholipase A2 inhibitor. shuts down entire prostaglandin/COX/thromboxane/leukotriene pathway

overall activates anti-inflammatory pathways and inhibits inflammatory pathways

SFM2 (11 decks)

Brainscape helps you reach your goals faster, through stronger study habits.
© 2024 Bold Learning Solutions. Terms and Conditions